Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Centene Corporation stock logo
CNC
Centene
$66.11
-1.4%		$64.89
$26.71
▼
$69.36
$33.13B1.085.28 million shs3.54 million shs
Cencora, Inc. stock logo
COR
Cencora
$310.13
-1.3%		$298.20
$244.82
▼
$377.54
$61.13B0.571.56 million shs1.54 million shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$23.63
-0.4%		$23.81
$20.02
▼
$27.64
$12.74B0.77806,531 shs508,656 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Centene Corporation stock logo
CNC
Centene
+3.47%+0.21%-1.81%+14.13%+157.09%
Cencora, Inc. stock logo
COR
Cencora
-5.99%-1.40%+2.18%+19.94%+8.22%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
-0.83%-0.82%-3.05%+10.31%-1.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Centene Corporation stock logo
CNC
Centene
$66.11
-1.4%		$64.89
$26.71
▼
$69.36
$33.13B1.085.28 million shs3.54 million shs
Cencora, Inc. stock logo
COR
Cencora
$310.13
-1.3%		$298.20
$244.82
▼
$377.54
$61.13B0.571.56 million shs1.54 million shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$23.63
-0.4%		$23.81
$20.02
▼
$27.64
$12.74B0.77806,531 shs508,656 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Centene Corporation stock logo
CNC
Centene
+3.47%+0.21%-1.81%+14.13%+157.09%
Cencora, Inc. stock logo
COR
Cencora
-5.99%-1.40%+2.18%+19.94%+8.22%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
-0.83%-0.82%-3.05%+10.31%-1.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Centene Corporation stock logo
CNC
Centene
2.40
Hold$69.154.60% Upside
Cencora, Inc. stock logo
COR
Cencora
2.87
Moderate Buy$374.2520.68% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.55
Reduce$23.57-0.25% Downside

Current Analyst Ratings Breakdown

Latest CNC, COR, and FMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Centene Corporation stock logo
CNC
Centene
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Buy$80.00
8/11/2026
Cencora, Inc. stock logo
COR
Cencora
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$331.00 ➝ $395.00
8/7/2026
Cencora, Inc. stock logo
COR
Cencora
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$342.00 ➝ $346.00
8/7/2026
Cencora, Inc. stock logo
COR
Cencora
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$382.00 ➝ $390.00
8/6/2026
Cencora, Inc. stock logo
COR
Cencora
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/6/2026
Cencora, Inc. stock logo
COR
Cencora
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$370.00
8/6/2026
Cencora, Inc. stock logo
COR
Cencora
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$412.00 ➝ $430.00
8/6/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Perform$25.50 ➝ $25.80
8/6/2026
Cencora, Inc. stock logo
COR
Cencora
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$350.00
8/6/2026
Cencora, Inc. stock logo
COR
Cencora
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/5/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$25.00
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Centene Corporation stock logo
CNC
Centene
$202.94B0.16$4.77 per share13.85$45.82 per share1.44
Cencora, Inc. stock logo
COR
Cencora
$321.33B0.19$20.07 per share15.45$16.65 per share18.63
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.20B0.57$5.51 per share4.29$29.29 per share0.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Centene Corporation stock logo
CNC
Centene
-$6.67B-$10.44N/A12.430.35-2.51%12.12%3.20%10/27/2026 (Estimated)
Cencora, Inc. stock logo
COR
Cencora
$1.55B$13.4623.0415.691.920.79%125.45%4.18%N/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9312.2410.054.434.83%9.28%4.16%N/A

Latest CNC, COR, and FMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q3 2026
Cencora, Inc. stock logo
COR
Cencora
$4.35$4.48+$0.13$3.94$84.31 billion$84.75 billion
8/3/2026Q2 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6160$0.66+$0.0440$0.46$5.48 billion$5.55 billion
7/28/2026Q2 2026
Centene Corporation stock logo
CNC
Centene
$1.09$2.51+$1.42$2.19$47.64 billion$53.58 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Centene Corporation stock logo
CNC
Centene
N/AN/AN/AN/AN/A
Cencora, Inc. stock logo
COR
Cencora
$2.400.77%+5.79%17.83%15 Years
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.58%+2.66%31.61%N/A

Latest CNC, COR, and FMS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/3/2026
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.600.76%8/14/20268/14/20268/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Centene Corporation stock logo
CNC
Centene
0.71
1.15
1.15
Cencora, Inc. stock logo
COR
Cencora
3.53
0.93
0.58
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.43
1.07
0.75

Institutional Ownership

CompanyInstitutional Ownership
Centene Corporation stock logo
CNC
Centene
93.63%
Cencora, Inc. stock logo
COR
Cencora
97.52%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
8.37%

Insider Ownership

CompanyInsider Ownership
Centene Corporation stock logo
CNC
Centene
0.37%
Cencora, Inc. stock logo
COR
Cencora
0.38%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Centene Corporation stock logo
CNC
Centene
61,100494.00 million492.17 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
51,000194.56 million193.82 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488537.13 millionN/AOptionable

Recent News About These Companies

Royal Bank of Canada Purchases 179,418 Shares of Fresenius Medical Care AG & Co. KGaA $FMS
August 13 at 4:48 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-purchases-179418-shares-of-fresenius-medical-care-ag-co-kgaa-fms-2026-08-13/
Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)
August 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/FMS/pressreleases/3656586/jefferies-remains-a-sell-on-fresenius-medical-care-ag-co-kgaa-0h9x/
Bernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
August 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/FMS/pressreleases/3655481/bernstein-keeps-their-hold-rating-on-fresenius-medical-care-ag-co-kgaa-0h9x/
Fresenius Medical Care AG & Co. KGaA $FMS Position Boosted by Sei Investments Co.
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-fresenius-medical-care-ag-co-kgaa-fms-position-boosted-by-sei-investments-co-2026-08-08/
Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call Presentation
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933500-fresenius-medical-care-ag-2026-q2-results-earnings-call-presentation
Quantinno Capital Management LP Boosts Stock Holdings in Fresenius Medical Care AG & Co. KGaA $FMS
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-boosts-stock-holdings-in-fresenius-medical-care-ag-co-kgaa-fms-2026-08-06/
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fresenius-medical-care-ag-co-kgaa-nysefms-receives-average-rating-of-reduce-from-brokerages-2026-08-06/
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
August 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2968783/fms-q2-earnings-rise-on-care-delivery-revenues-miss-margins-expand?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2968783
Fresenius Medical Care AG & Co. KGaA Q2 2026 Earnings Call Summary
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/fresenius-medical-care-ag-co-220035761.html
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4929816-fresenius-medical-care-ag-fms-q2-2026-earnings-call-transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Trading Down 6% - Time to Sell?
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fresenius-medical-care-ag-co-kgaa-nysefms-trading-down-6-time-to-sell-2026-08-04/
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fresenius-medical-care-ag-co-kgaa-q2-earnings-call-highlights-2026-08-04/
Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further
August 4, 2026  |  wsj.comhttps://www.wsj.com/business/earnings/fresenius-medical-care-shares-drop-after-u-s-treatment-volumes-fall-further-2d857506
Kioxia Showcases Flash Storage Innovations for the AI Era at FMS 2026
August 4, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260803680678/en/Kioxia-Showcases-Flash-Storage-Innovations-for-the-AI-Era-at-FMS-2026/
Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again
August 4, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/dialysis-firm-fmcs-shares-slide-despite-earnings-beat-us-volumes-disappoint-2026-08-04/
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Announces Earnings Results
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fresenius-medical-care-ag-co-kgaa-nysefms-announces-earnings-results-2026-08-03/
Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook
August 3, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/fresenius-medical-care-beats-quarterly-profit-estimates-sticks-2026-outlook-2026-08-03/
Fresenius Medical Care AG & Co. KGaA (FMS) Expected to Post Earnings on Tuesday
August 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30937554
BNP Paribas Exane Upgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to "Strong Sell"
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/bnp-paribas-exane-upgrades-fresenius-medical-care-ag-co-kgaa-nysefms-to-strong-sell-2026-07-30/
Fresenius Medical Care AG & Co. KGaA (FMS) Expected to Post Quarterly Earnings on Tuesday
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fresenius-medical-care-ag-co-kgaa-fms-expected-to-post-quarterly-earnings-on-tuesday-2026-07-28/
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
July 23, 2026  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1095944?snapi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
A semi-truck hauls a large cylindrical industrial component past police cars on a nighttime industrial roadway.
These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
By Nathan Reiff | July 28, 2026
Rows of server racks with blue network cables and storage drives in a data center aisle.
Which Storage Stock Is Best Positioned to Win the AI Memory War?
By Nathan Reiff | July 16, 2026
Microsoft logo displayed on a wall-mounted plaque in a modern office lobby with glass partitions.
Microsoft Just Flipped the AI Spending Narrative Overnight
By Chris Markoch | July 30, 2026
Centene stock logo

Centene NYSE:CNC

$66.11 -0.96 (-1.43%)
Closing price 03:59 PM Eastern
Extended Trading
$66.06 -0.05 (-0.08%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Cencora stock logo

Cencora NYSE:COR

$310.13 -4.04 (-1.29%)
Closing price 03:59 PM Eastern
Extended Trading
$307.68 -2.44 (-0.79%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$23.63 -0.09 (-0.40%)
Closing price 03:59 PM Eastern
Extended Trading
$23.64 +0.01 (+0.04%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas